lunes, 2 de marzo de 2026

Psoriasis: Addressing Weight Loss in Patients | How Biologics Continue to Transform Dermatologic Care +++++ +

Weight Loss and Psoriasis: How to Talk With Patients and Take a Comprehensive Approach Christine Kilgore https://www.medscape.com/viewarticle/weight-loss-and-psoriasis-how-talk-patients-and-take-2026a100023y?ecd=mkm_ret_260302_mscpmrk-OUS_InFocus_etid8138823&uac=148436CN&impID=8138823 January 22, 2026 Bimekizumab Eases Plaque Psoriasis Symptoms Up to 3 Years Edited by Deepa Varma https://www.medscape.com/viewarticle/bimekizumab-eases-plaque-psoriasis-symptoms-3-years-2026a100052j?ecd=mkm_ret_260302_mscpmrk-OUS_InFocus_etid8138823&uac=148436CN&impID=8138823 February 18, 2026 Biologics Continue to Transform Dermatology, With Safer and More Effective Care Damian McNamara, MA https://www.medscape.com/viewarticle/biologics-continue-transform-dermatology-safer-and-more-2026a10004du?ecd=mkm_ret_260302_mscpmrk-OUS_InFocus_etid8138823&uac=148436CN&impID=8138823 February 11, 2026 Pediatric Psoriasis Lacks Clear Guidance for Everyday Care Caroline Guignot https://www.medscape.com/viewarticle/pediatric-psoriasis-lacks-clear-guidance-everyday-care-2026a10001iq?ecd=mkm_ret_260302_mscpmrk-OUS_InFocus_etid8138823&uac=148436CN&impID=8138823 Medscape Europe January 16, 2026 Biologic Plus GLP-1 Agonist Improves Quality of Life in Psoriatic Disease Ted Bosworth https://www.medscape.com/viewarticle/biologic-plus-glp-1-agonist-improves-quality-life-psoriatic-2026a10002s0?ecd=mkm_ret_260302_mscpmrk-OUS_InFocus_etid8138823&uac=148436CN&impID=8138823 January 28, 2026 Patient with plaque psoriasis asking about a study mentioned in online support group about high dose risankizumab. What is the latest? (Medscape AI) https://www.medscape.com/ai-search?query=Patient%20with%20plaque%20psoriasis%20asking%20about%20a%20study%20mentioned%20in%20online%20support%20group%20about%20high%20dose%20risankizumab.%20What%20is%20the%20latest%3F&&ecd=mkm_ret_260302_mscpmrk-OUS_InFocus_etid8138823&uac=148436CN&impID=8138823

No hay comentarios:

Publicar un comentario